Friday, November 1, 2024 from Medical Xpress - Parkinson's & Movement disorders News
Brain disorders like Parkinson's disease (PD) or Alzheimer's disease (AD) start to develop in patients much earlier than when their first clinical symptoms appear. Treating patients at these early stages could slow or even stop their...Friday, November 1, 2024 from Medical Xpress - Parkinson's & Movement disorders News
A team of researchers at Kumamoto University has uncovered a mechanism in the formation of harmful protein aggregates that lead to neurodegenerative diseases such as Parkinson's disease.Friday, November 1, 2024 from News-Medical.Net Parkinsons Disease News Feed
Rapid side-to-side eye movements can help stabilize posture, avoid falls and maintain balance for people with Parkinson's disease, just as they can for healthy people. This seemingly counterintuitive conclusion was reached by researchers...Thursday, October 31, 2024 from Medical Xpress - Parkinson's & Movement disorders News
Using sequencing techniques, researchers associated 51 mutations in mitochondrial DNA with amyotrophic lateral sclerosis (ALS), an incurable degenerative neurological disorder that leads to muscle atrophy and paralysis. Thirteen of the...Thursday, October 31, 2024 from Medical Xpress - Parkinson's & Movement disorders News
A drug commonly used to treat glaucoma has been shown in zebrafish and mice to protect against the build-up in the brain of the protein tau, which causes various forms of dementia and is implicated in Alzheimer's disease.Wednesday, October 30, 2024 from Medical Xpress - Parkinson's & Movement disorders News
Rapid side-to-side eye movements can help stabilize posture, avoid falls and maintain balance for people with Parkinson's disease, just as they can for healthy people. This seemingly counterintuitive conclusion was reached by researchers...Wednesday, October 30, 2024 from ScienceDaily: Parkinson's Research News
The amount of money people pay out-of-pocket for branded drugs to treat neurological diseases like multiple sclerosis (MS), Alzheimer's, and Parkinson's disease continues to rise, especially for MS drugs, according to a new study. The...Tuesday, October 29, 2024 from News-Medical.Net Parkinsons Disease News Feed
Ultrasound, once used almost exclusively to take images of the body, is quickly developing into a targeted therapy that can have a potentially life-changing impact on our brains, according to the authors of a new article.Monday, October 28, 2024 from Medical Xpress - Parkinson's & Movement disorders News
Researchers from the University of Oxford have identified a key biochemical mechanism relevant to the development of Huntington's disease. This discovery opens up the possibility of studying the disease before its clinical onset and...Monday, October 28, 2024 from News-Medical.Net Parkinsons Disease News Feed
Antibiotic exposure shows potential protective effects against Parkinson's, while antifungal use is linked to increased risk, indicating microbiome involvement.Saturday, October 26, 2024 from Medical Xpress - Parkinson's & Movement disorders News
The human brain is a marvel of complexity. It contains specialized and interconnected structures controlling our thoughts, personality and behavior.Thursday, October 24, 2024 from Medical Xpress - Parkinson's & Movement disorders News
A new mouse model mimicking the liver symptoms of myotonic dystrophy type 1—the most prevalent form of adult-onset muscular dystrophy—provides insight into why patients develop fatty liver disease and display hypersensitivity to...Wednesday, October 23, 2024 from ScienceDaily: Parkinson's Research News
Research highlights a complex relationship between bacteria in the digestive tract and brain health.Wednesday, October 23, 2024 from Medical Xpress - Parkinson's & Movement disorders News
A Rutgers Health study has found that people who took multiple courses of penicillin antibiotics had a modestly lower risk of developing Parkinson's disease, a surprising finding that researchers say highlights the complex relationship...Wednesday, October 23, 2024 from Medical Xpress - Parkinson's & Movement disorders News
The U.S. Food and Drug Administration has approved AbbVie's Vyalev (foscarbidopa and foslevodopa) for adults living with advanced Parkinson's disease (PD).Wednesday, October 23, 2024 from Medical Xpress - Parkinson's & Movement disorders News
Oregon Health & Science University-led researchers have found a correlative link between hearing loss and the development of Parkinson's disease (PD). They find the risk of PD rises somewhat with the severity of hearing loss, and...Wednesday, October 23, 2024 from News-Medical.Net Parkinsons Disease News Feed
Advancements in organoid technology are crucial for Parkinson's disease research, providing human-relevant models for studying disease and testing therapies.Monday, October 21, 2024 from Medical Xpress - Parkinson's & Movement disorders News
In one of the largest-ever studies of DNA and brain volume, researchers have identified 254 genetic variants that shape key structures in the "deep brain," including those that control memory, motor skills, addictive behaviors and more....Monday, October 21, 2024 from Medical Xpress - Parkinson's & Movement disorders News
A Phase 3 clinical trial investigating Elevidys (delandistrogene moxeparvovec), a gene therapy for Duchenne muscular dystrophy, did not achieve its primary endpoint, according to findings published in Nature Medicine. A News and Views...Monday, October 21, 2024 from News-Medical.Net Parkinsons Disease News Feed
In one of the largest-ever studies of DNA and brain volume, researchers have identified 254 genetic variants that shape key structures in the "deep brain," including those that control memory, motor skills, addictive behaviors and more.Thursday, October 17, 2024 from ScienceDaily: Parkinson's Research News
Neuroscientists have uncovered a mechanism that controls the reactivation of neural stem cells, which are crucial for repairing and regenerating brain cells. The research offers exciting potential for advancing our understanding and...Wednesday, October 16, 2024 from Medical Xpress - Parkinson's & Movement disorders News
The chemical messenger dopamine is an essential catalyst that fuels activities and behaviors ranging from movement to cognition and learning. However, neuroscientists have long debated whether these functions rely on rapid bursts of...Wednesday, October 16, 2024 from Medical Xpress - Parkinson's & Movement disorders News
It's well known that Parkinson's disease can impair a person's ability to perform movements like grabbing a coffee cup, with one side of the body often more affected. But a recent study published in Brain and Cognition by University of...Tuesday, October 15, 2024 from Medical Xpress - Parkinson's & Movement disorders News
A team of researchers has identified a promising therapy based on antimiRs to treat myotonic dystrophy type 1 (DM1), a complex genetic disorder caused by an abnormally high number of CTG repeats (a specific type of RNA sequence) in the...Monday, October 14, 2024 from Medical Xpress - Parkinson's & Movement disorders News
A toxic version of a certain protein may affect brain, spinal cord and skeletal muscle tissues differently, leading to the complex development and progression of amyotrophic lateral sclerosis (ALS), according to a new study by a team of...Monday, October 14, 2024 from News-Medical.Net Parkinsons Disease News Feed
Researchers at Uppsala University have developed a clinical model that can accurately predict the risk of hip fractures in the elderly.Monday, October 14, 2024 from Medical Xpress - Parkinson's & Movement disorders News
Lewy body dementia (LBD) is a progressive neurodegenerative disease that shares traits with both Parkinson's disease and Alzheimer's disease but can be more difficult to diagnose. Symptoms can include hallucinations, movement disorders,...Sunday, October 13, 2024 from News-Medical.Net Parkinsons Disease News Feed
In collaboration with the International Conference on Research in Computational Molecular Biology (RECOMB), Genome Research publishes a collection of 20 computational methods and their applications in genomics including spatial,...Saturday, October 12, 2024 from News-Medical.Net Parkinsons Disease News Feed
Novel magnetic nanodiscs could provide a much less invasive way of stimulating parts of the brain, paving the way for stimulation therapies without implants or genetic modification, MIT researchers report.Friday, October 11, 2024 from Medical Xpress - Parkinson's & Movement disorders News
A research team has published a randomized clinical trial demonstrating for the first time that a multidisciplinary approach integrating specific physiotherapy and cognitive-behavioral therapy is effective in improving the symptoms and...Thursday, October 10, 2024 from News-Medical.Net Parkinsons Disease News Feed
A new technology enables the control of specific brain circuits non-invasively with magnetic fields, according to a preclinical study from researchers at Weill Cornell Medicine, The Rockefeller University and the Icahn School of Medicine...Thursday, October 10, 2024 from ScienceDaily: Parkinson's Research News
A new technology enables the control of specific brain circuits non-invasively with magnetic fields, according to a preclinical study. The technology holds promise as a powerful tool for studying the brain and as the basis for future...Tuesday, October 8, 2024 from News-Medical.Net Parkinsons Disease News Feed
Lewy bodies are a hallmark of Parkinson's disease (PD) and other related neurological conditions. Understanding why and how they develop is critical to developing better treatments.Tuesday, October 8, 2024 from ScienceDaily: Parkinson's Research News
Scientists have recreated the growth of Lewy bodies in human neurons and followed their formation to gain important insight into why and how they form. Critically, they find that immune challenge is important for this process,...Tuesday, October 8, 2024 from Medical Xpress - Parkinson's & Movement disorders News
Lewy bodies are a hallmark of Parkinson's disease (PD) and other related neurological conditions. Understanding why and how they develop is critical to developing better treatments.Friday, October 4, 2024 from ScienceDaily: Parkinson's Research News
A research team has revealed that a molecule in the brain -- ophthalmic acid -- unexpectedly acts like a neurotransmitter similar to dopamine in regulating motor function, offering a new therapeutic target for Parkinson's and other...Friday, October 4, 2024 from Medical Xpress - Parkinson's & Movement disorders News
A research team from the University of California, Irvine is the first to reveal that a molecule in the brain—ophthalmic acid—unexpectedly acts like a neurotransmitter similar to dopamine in regulating motor function, offering a new...Wednesday, October 2, 2024 from Parkinson's Disease New Links: MedlinePlus RSS Feed
Tuesday, October 1, 2024 from Medical Xpress - Parkinson's & Movement disorders News
Reduced brain activity responding to unpredicted visual changes is a marker of psychosis in Parkinson's disease and a potential therapeutic target. Researchers at the IoPPN used electroencephalography (EEG) to observe participant's brain...Friday, September 27, 2024 from ScienceDaily: Parkinson's Research News
Listening to people with Parkinson's disease made an automatic speech recognizer 30-percent more accurate, according to a new study.Friday, September 27, 2024 from Medical Xpress - Parkinson's & Movement disorders News
As Mark Hasegawa-Johnson combed through data from his latest project, he was pleasantly surprised to uncover a recipe for Eggs Florentine. Sifting through hundreds of hours of recorded speech will unearth a treasure or two, he said.Friday, September 27, 2024 from Medical Xpress - Parkinson's & Movement disorders News
For 12 years, Paul Stroud's done everything he can to combat the effects of Parkinson's disease. He had a pair of stimulators implanted deep in his brain. He takes the standard medications to treat symptoms. He even briefly tried out tai...Thursday, September 26, 2024 from Medical Xpress - Parkinson's & Movement disorders News
Deep brain stimulation is an effective treatment for motor symptoms in patients with movement disorders such as Parkinson's disease. While ultimately regarded as safe, DBS can yield noticeable declines in verbal fluency, which affects...Thursday, September 26, 2024 from Medical Xpress - Parkinson's & Movement disorders News
A team of scientists led by Prof. Patrik Verstreken (VIB-KU Leuven) has identified a new genetic mutation that may cause a form of early-onset Parkinsonism. The research has been published in Cell Reports Medicine.Thursday, September 26, 2024 from Medical Xpress - Parkinson's & Movement disorders News
Parkinson's disease (PD), the second most common neurodegenerative disorder globally, has long baffled scientists with its progressive nature and debilitating effects on motor function.Wednesday, September 25, 2024 from Medical Xpress - Parkinson's & Movement disorders News
Researchers at the Jan and Dan Duncan Neurological Research Institute (NRI) at Texas Children's Hospital and Baylor College of Medicine recently made an important advance in neurodegenerative disease research and modeling. They created a...Tuesday, September 24, 2024 from ScienceDaily: Parkinson's Research News
Parkinson's disease, a debilitating nervous system disorder, is treated with medications that sometimes cause impaired decision-making and poor impulse control. Now, researchers have identified a structure in the brain called the...Tuesday, September 24, 2024 from Medical Xpress - Parkinson's & Movement disorders News
Parkinson's disease (PD), also known simply as Parkinson's, is a disorder of the nervous system that affects millions of people worldwide. The nerve cell damage associated with Parkinson's can cause tremors, slowed movements, problems...Tuesday, September 24, 2024 from Medical Xpress - Parkinson's & Movement disorders News
The number of people living with Parkinson's disease globally has doubled in the past 25 years. Yet the treatment and monitoring of the neurological disease seems many decades behind. Clinicians typically gauge the severity of the...Wednesday, September 18, 2024 from ScienceDaily: Parkinson's Research News
A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a new study.